| What would the
Expert do? |
|
| 07.15-08.15 |
Royal Hall, HIC |
Chair: Weetman AP (Sheffield) |
|
|
Abnormal thyroid function
in pregnancy |
|
|
Lazarus JH (Cardiff) |
|
| |
|
|
|
| What would the
Expert do? |
|
| 07.15-08.15 |
Spa Suite, Majestic Hotel |
Chair: Zweit J (Manchester) |
|
|
New imaging techniques:
from live cells to whole organisms |
|
|
White MRH (Liverpool) |
|
|
|
|
|
| What would the
Expert do? |
|
| 07.15-08.15 |
King’s Suite, HIC |
Chair: Franks S (London) |
|
|
Ovulation induction |
|
|
|
Buckler HM (Manchester) |
|
| |
|
|
|
| Society for
Endocrinology Transatlantic Medal Lecture |
| 08.30-09.30 |
Main Auditorium, HIC |
Chair: Franks S (London) |
| S2 |
08.30 |
Mechanisms of preterm
birth, and influences on disease in later life |
|
|
Challis JRG (Toronto),
Lye SJ, Gibb W, Dong X, Bloomfield F, Patel F, Sloboda D, Newnham J,
Gupta S, Giannoulias D, Whittle W & Alfaid N |
| |
|
|
|
| TEA/COFFEE |
|
|
| 09.30-10.00 |
Hall D, HIC |
|
| |
|
|
|
| Symposium 1:
Hormonal control of female reproduction |
GENEROUSLY SUPPORTED
BY OXFORD BIO-INNOVATION-DSL
|
| 10.00-12.00 |
Royal Hall, HIC |
Chair: Hillier SG (Edinburgh) |
| S6 |
10.00 |
Transgenic models to
study ovarian folliculogenesis and oogenesis |
|
|
Matzuk MM (Houston) |
| S7 |
10.30 |
The generation of the
preovulatory LH surge |
|
|
McNeilly AS (Edinburgh) |
| S8 |
11.00 |
Role of cofactors for
nuclear receptors in reproduction |
|
|
Milligan SR (London),
White R, Leonardsson G, Soulez M, Jacobs M, Rosewell I & Parker M |
| S9 |
11.30 |
Role of COX-2 in implantation |
|
|
Dey SK (Kansas) |
| |
|
|
| Clinical Management
Workshop 1: Insulin resistance and type 2 diabetes in adolescents and
young adults |
| 10.00-12.00 |
Main Auditorium, HIC |
Chair: Dunger DB (Cambridge) |
| S34 |
|
Epidemiology of type
2 diabetes in childhood and adolescents in North America: possible lessons
for the UK |
|
|
Engelgau MM (Atlanta) |
| S35 |
|
Pathophysiology of type
2 diabetes in adolescents and young adults |
|
|
Arslanian S (Pittsburgh) |
| S36 |
|
Management of adolescents
and young adults with insulin resistance |
|
|
Lee WRW (Singapore) |
| |
|
|
| Oral Communications
1: Genetics: new insights into endocrine disease |
| 10.00-12.00 |
King’s Suite, HIC |
Chair: Dominiczak AF (Glasgow) & Pearce
SHS (Newcastle) |
| OC1 |
10.00 |
All in the family: site
and gender specificity of the genetic control of bone mineral density |
|
|
Duncan EL, Cardon
L, Wass JAH & Brown MA |
| OC2 |
10.15 |
GATA3 mutations in the
hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome |
|
|
Nesbit MA, Bowl MR,
Harding B, Crowe C, Dobbie A, Hampson G, Holdaway I, Rigden S, Sampson
J & Thakker RV |
| OC3 |
10.30 |
A molecular deletional-insertion
involving chromosomes Xq27 and 2p25 causes X-linked recessive hypoparathyroidism |
|
|
Bowl MR, Nesbit MA,
Harding B, Levy E, Schlessinger D, Whyte MP & Thakker RV |
|
|
NOVARTIS
AWARDS WINNER (NP1), ALSO PRESENTED AT TWO DEDICATED POSTER SESSIONS:
TUESDAY AT 14.00–14.30 AND WEDNESDAY AT 13.30–14.00, BOTH IN
HALL D, HIC |
| OC4 |
10.45 |
Analysis of novel mutations
in the HSD11b2 gene: implications for AME and
possibly IUGR |
|
|
Lavery GG, Ronconi
V, Draper N, Chalder SM, Walker EA, Mcternan CL, Mantero F, Hewison M & Stewart
PM |
| OC5 |
11.00 |
Identification of differentially
expressed genes in rat chromosome 2 congenic strains |
|
|
McBride MW, Carr
FJ, Graham D, Clark JS, Strahorn P, Anderson NH & Dominiczak AF |
| OC6 |
11.15 |
Y chromosome consomic
strains and metabolic syndrome in the stroke prone spontaneously hypertensive
rat |
|
|
Strahorn P, Graham
D, Crawford L, Morton JJ, Sattar N & Dominiczak AF |
| OC7 |
11.30 |
The vitamin D receptor
gene is associated with susceptibility to development of Graves’ disease
in the UK |
|
|
Collins JE, Heward
JM, Allahabadia A, Franklyn JA, Gough SCL & Nithiyananthan R |
| OC8 |
11.45 |
Identification and characterization
of a novel missense mutation in the growth hormone gene in a child with
short stature |
|
|
Lewis MD, Procter
AM, Millar DS, Horan M, Easter TE, Newsway V, Fryklund L, Gregory J,
Scanlon MF & Cooper DN |
| |
|
|
| Oral Communications
2: Endocrine neoplasia |
| 10.00-12.00 |
Spa Suite, Majestic Hotel |
Chair: Hewison M (Birmingham) & Farrell
WE (Stoke-on-Trent) |
| OC9 |
10.00 |
Breast cancer cells
express the vitamin D activating enzyme 1a-hydroxylase |
|
|
Townsend K, Evans
KN, Hughes SV, Mørk Hansen C, Colston KW, Campbell MJ & Hewison M
MICHAEL WHITE MEMORIAL PRIZE WINNER |
|
|
|
| OC10 |
10.15 |
2-Methoxyestradiol
sulphamates induce G2-M arrest and apoptosis in ER-VE MDA-MB-231 breast
cancer cells |
|
|
Malini
B, Purohit A, Leese MP, Potter BVL & Reed MJ |
| OC11 |
10.30 |
CYP24
action: an intrinsic mechanism of resistance in breast and prostate cancer
cells |
|
|
Moore
J, Miles AE, Townsend K, Colston KW, Stewart PM, Hewison M & Campbell
MJ |
| OC12 |
10.45 |
Ghrelin
inhibits proliferation of breast cell lines acting via the growth hormone
secretagogue receptor (GHS-R) |
|
|
Taylor
JP, Hughes BA, Sheppard MC, Stewart PM & Toogood AA |
| OC13 |
11.00 |
Disruption
of the SH3 domain of pituitary tumor transforming gene (PTTG) reveals
distinct mechanisms of FGF-induction and cell transformation |
|
|
Boelaert
K, Tannahill LA, McRobbie LJ, Moore JS, Young LS, Sheppard MC, Franklyn
JA, Gittoes NJL & McCabe CJ |
| OC14 |
11.15 |
Expression
and function of vascular endothelial growth factor (VEGF) and its receptor
KDR in pituitary tumours |
|
|
McCabe
CJ, Boelaert K, Tannahill LA, Khaira JS, McRobbie LJ, Hussain S, Sheppard
MC, Gittoes NJL & Franklyn JA |
| OC15 |
11.30 |
Regional
gene expression in the colon of patients with and without acromegaly |
|
|
Kelly
PA, Ogunkolade BW, Fairclough PA, Monson JP, Grossman AB, Besser GM,
Bustin SA & Jenkins PJ |
| OC16 |
11.45 |
BPDZ-154
is a potent activator of ATP-sensitive potassium channels in pancreatic b-cells |
|
|
Lee
AT, Cosgrove KE, Barnes PD, Lindley KJ, Aynsley-Green A, de Tullio
P, Pirotte B, Lebrun P & Dunne MJ |
| |
|
|
| Extraordinary
General Meeting of the Society for Endocrinology |
| 12.00-12.30 |
Main
Auditorium, HIC |
|
|
|
| LUNCH |
|
| 12.00-14.00 |
Hall
D, HIC |
| |
|
|
| Ipsen
Satellite Symposium: Somatostatin analogues: clinical update on new
developments |
| 12.30-14.00 |
Main
Auditorium, HIC |
| |
|
|
| Novartis
Awards Poster Session |
| 14.00-14.30 |
Hall
D, HIC |
| |
|
|
| Attended
Posters (even numbers) |
| 14.00-15.30 |
Hall
D, HIC |
| |
|
|
| Symposium
2: Recent advances in biological rhythms |
| 15.30-17.30 |
Spa Suite, Majestic
Hotel |
Chair: Loudon
ASI (Manchester) |
| S10 |
15.30 |
Molecular
mechanisms of the circadian clockwork |
|
|
Hastings
MH (Cambridge) |
| S11 |
16.00 |
Photoperiodic
regulation of the neuroendocrine system |
|
|
Morgan
PJ (Aberdeen), Ross AW, Mercer J & Barrett P |
| S12 |
16.30 |
Human physiological
implications of biological timing |
|
|
Arendt J (Guildford) |
| S13 |
17.00 |
Endocrine and other
biological rhythms in man |
|
|
Wehr TA (Bethesda),
Duncan Jr WC & Aeschbach D |
| |
|
|
| Symposium 3:
Vascular risk in diabetes - genetic and environmental interactions |
| 15.30-17.30 |
Royal Hall, HIC |
Chair: Connell JMC (Glasgow) |
| S14 |
15.30 |
Diabetes and vascular
risk |
|
|
Holman RR (Oxford) |
| S15 |
16.00 |
Genetic basis of type
2 diabetes |
|
|
Hattersley AT (Exeter) |
| S16 |
16.30 |
From QTL locus to insulin
resistance gene |
|
|
Aitman TJ (London) |
| S17 |
17.00 |
Lifestyle and environmental
interactions in type 2 diabetes |
|
|
Laakso M (Kuopio) |
| |
|
|
| Clinical Management
Workshop 2: New treatments for osteoporosis |
| GENEROUSLY SUPPORTED
BY ELI LILLY & COMPANY |
| 15.30-17.30 |
Main Auditorium, HIC |
Chair: Eastell R (Sheffield) & Russell
RGG (Oxford) |
| S37 |
|
Prospects for new treatment
approaches in osteoporosis |
|
|
Russell RGG (Oxford) |
| S38 |
|
Parathyroid hormone
for osteoporosis treatment |
|
|
Lindsay R (New York) |
| S39 |
|
Statins for the prevention
of postmenopausal osteoporosis |
|
|
Eastell R (Sheffield) |
| |
|
|
| Oral Communications
3: Growth regulation |
| 15.30-17.30 |
King’s Suite, HIC |
Chair: Di Lauro R (Naples) & Logan
A (Birmingham) |
| OC17 |
15.30 |
The identification of
cryptic gene sequences that encode putative ligands: the example of POP1 |
|
|
Baird A (London),
Burg M, Jensen-Pergakes K, Ravey P, Gonzalez AM & Larocca D
WINNING ABSTRACT FROM THE 2001 BES AWARDS SUPPORTED BY
PHARMACIA |
| OC18 |
15.45 |
Overexpression of insulin-like
growth factor binding protein-5 (IGFBP-5) induces severe growth retardation
in transgenic mice |
|
|
Salih DAM, Szestak
TAM, Carter EJ, Gonzalez I, Eisemann JH & Pell JM |
| OC19 |
16.00 |
Thyroid hormone activates
fibroblast growth factor receptor-1 in bone |
|
|
Scott AJ, Harvey
CB, O’Shea PJ, Stevens DA, Samarut J, Chassande O & Williams
GR |
| OC20 |
16.15 |
Advanced bone formation
in mice with resistance to thyroid hormone due to a targeted mutation in
the thyroid hormone receptor b gene |
|
|
O’Shea PJ, Harvey
CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng S-Y & Williams GR |
| OC21 |
16.30 |
Decidual
matrix metalloproteases MMP-3 and MMP-9 proteolyse insulin-like growth
factor binding protein-1 |
|
|
Coppock
HA, Aplin JD, White A & Westwood M |
| OC22 |
16.45 |
The epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’)
inhibits growth of human pituitary cells expressing a mutated form of
the EGFR |
|
|
Borg
SA, Kerry KE, Suliman ME, Royds JA, Wharton SB & Jones TH |
| OC23 |
17.00 |
Follicle-stimulating
hormone and transforming growth factor-b superfamily
members regulate granulosa cell connective tissue growth factor (CTGF)
gene expression in vitro and in vivo |
|
|
Harlow
CR, Davidson L, Burns KH, Yan C, Matzuk MM & Hillier SG |
| OC24 |
17.15 |
Abnormalities
of folliculogenesis in polycystic ovaries start at the primordial stage |
|
|
Webber
LJ, Wright CS, Stubbs S, Margara R, Trew GM, Hardy K & Franks S |
| TEA/COFFEE |
|
| 17.30-18.00 |
Hall
D, HIC |
| |
|
|
| Clinical
Endocrinology Trust Visiting Professor Lecture |
| 18.00-19.00 |
Main
Auditorium, HIC Chair: Rees LH (London) |
| S3 |
18.00 |
The neuroendocrinology
of stress |
|
|
Chrousos
GP (Bethesda) |
| |
|
|
| Pharmacia
Satellite Symposium: Clinical dilemmas in growth hormone deficiency |
| 19.15-21.15 |
Main
Auditorium, HIC |
| |
|
|